| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 03/19/1997 | EP0763118A1 Transgenic plants producing trehalose |
| 03/19/1997 | EP0763117A1 Synthetic leader peptide sequences |
| 03/19/1997 | EP0763112A1 Process for preparing doxorubicin |
| 03/19/1997 | EP0763110A2 Mn gene and protein |
| 03/19/1997 | EP0763109A1 Factor interacting with nuclear proteins |
| 03/19/1997 | EP0763106A1 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 03/19/1997 | EP0763105A1 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof |
| 03/19/1997 | EP0763104A1 Human dna topoisomerase i-alpha |
| 03/19/1997 | EP0763101A1 Nucleic acid sequences and expression systems for heparinase ii and heparinase iii derived from flavobacterium heparinum |
| 03/19/1997 | EP0763057A1 Method for proliferating and differentiating b cells, and uses thereof |
| 03/19/1997 | EP0763046A1 Dna encoding gls1 |
| 03/19/1997 | EP0762894A1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
| 03/19/1997 | EP0762892A1 Diphtheria toxin vaccines bearing a mutated r domain |
| 03/19/1997 | EP0762889A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation |
| 03/19/1997 | EP0762885A1 Glial mitogenic factors, their preparation and use |
| 03/19/1997 | EP0596881B1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector |
| 03/19/1997 | EP0495960B1 Methods for rapid microbial detection |
| 03/19/1997 | CN1145640A Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
| 03/19/1997 | CN1145638A Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 03/19/1997 | CN1145637A Alpha-1-antichymotrypsin analogues having elastase inhibitory activity |
| 03/19/1997 | CN1145589A Method for antigen-specific immunoregulation by T-Cell alpha chain |
| 03/19/1997 | CA2182541A1 Novel, ubiquitous potassium-channel proteins and genes for the same |
| 03/19/1997 | CA2181880A1 Atp-sensitive potassium-channel proteins and their genes |
| 03/18/1997 | US5612486 Transgenic animals harboring APP allele having swedish mutation |
| 03/18/1997 | US5612217 Streptomyces sp. MA 7074 (ATCC 55605) used for microbial synthesis of HIV protease inhibitors |
| 03/18/1997 | US5612213 Vector for increased expression of recombinant factor viii |
| 03/18/1997 | US5612210 Culture of escherichia to produce enzyme |
| 03/18/1997 | US5612206 Retrovirus infecting primate bone marrow cells and harvesting both non-adherent and adherent cells |
| 03/18/1997 | US5612197 Process for producing recombinant human serum albumin |
| 03/18/1997 | US5612196 Introducing exogenous dna code human serum albumin and culture in medium of ethanol, glycerol, sorbitol, sucrose or esters and recovering |
| 03/18/1997 | US5612195 Recombinant production of a human interferon (IFN)-gamma antagonist cytokine |
| 03/18/1997 | US5612190 Screening for vasodilators |
| 03/18/1997 | US5612029 Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| 03/15/1997 | CA2185517A1 Use of cytohesin-ph peptides for influencing the ability of integrins to adhere |
| 03/13/1997 | WO1997009451A1 Cloned dna polymerases from thermotoga and mutants thereof |
| 03/13/1997 | WO1997009446A1 Phage display for detergent enzyme activity |
| 03/13/1997 | WO1997009441A2 Improved aav vectors for gene therapy |
| 03/13/1997 | WO1997009438A1 Process for modifying glucose repression |
| 03/13/1997 | WO1997009437A1 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 03/13/1997 | WO1997009435A1 Plasmid stabilization |
| 03/13/1997 | WO1997009429A2 Compounds and methods for diagnosis of tuberculosis |
| 03/13/1997 | WO1997009427A1 Vegf-related protein |
| 03/13/1997 | WO1997009422A1 Overexpression of recombinant bacteriophage t4 endonuclease vii and uses thereof |
| 03/13/1997 | WO1997009418A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 03/13/1997 | WO1997006268A3 Dna constructs |
| 03/13/1997 | WO1997006261A3 The use of homologous amds genes as selectable markers |
| 03/13/1997 | WO1997005256A3 Mammalian pro-hormone convertase |
| 03/13/1997 | WO1996034964A3 Stable variant hk2 polypeptide |
| 03/13/1997 | WO1996033279A3 Repertoire cloning process, products derived therefrom and uses for said products |
| 03/13/1997 | CA2231400A1 Vegf-related protein |
| 03/13/1997 | CA2231372A1 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 03/13/1997 | CA2230927A1 Compounds and methods for diagnosis of tuberculosis |
| 03/13/1997 | CA2230858A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 03/13/1997 | CA2230758A1 Improved aav vectors for gene therapy |
| 03/13/1997 | CA2230099A1 Overexpression of recombinant bacteriophage t4 endonuclease vii and uses thereof |
| 03/12/1997 | EP0761817A2 Process for the preparation of vanillin and suitable microorganisms |
| 03/12/1997 | EP0761815A2 Bacillus thuringiensis sporulation gene |
| 03/12/1997 | EP0761814A1 Antibody 103 B2 to a peanut agglutinin(PNA)-binding glycoprotein on cell surfaces |
| 03/12/1997 | EP0761685A2 Macrophage-derived inflammatory mediator (mip-1 alpha and mip-1 beta) |
| 03/12/1997 | EP0761230A2 Vaccine containing Bordetella pertussis outer membrane protein, and method of making such vaccine |
| 03/12/1997 | EP0761096A1 Insecticidal matrix and process for preparation thereof |
| 03/12/1997 | EP0761034A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch |
| 03/12/1997 | EP0760866A1 Method and culture medium for identification of salmonellae |
| 03/12/1997 | EP0760864A1 Dna encoding glutamate gated chloride channels |
| 03/12/1997 | EP0760863A1 Method and means for the production of hyaluronic acid |
| 03/12/1997 | EP0760859A1 Shuttle vectors for the introduction of dna into mycobacteria and utilization of such bacteria as vaccines |
| 03/12/1997 | EP0760857A1 Receptor for oncostatin m |
| 03/12/1997 | EP0760856A1 Microorganisms permitting the intracellular polyhydroxy alkanoate synthesis with simultaneous extracellular polysaccharide synthesis and processes for producing the same |
| 03/12/1997 | EP0760850A1 P2x RECEPTORS (PURINOCEPTOR FAMILY) |
| 03/12/1997 | EP0760849A1 Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof |
| 03/12/1997 | EP0760848A1 Lactobacillus strains of human origin, their compositions and uses thereof |
| 03/12/1997 | EP0760823A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
| 03/12/1997 | EP0760602A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
| 03/12/1997 | EP0644774A4 Improved production of reproductive hormones. |
| 03/12/1997 | EP0552191B1 Micro-organism and process for obtaining anthranilic acid |
| 03/12/1997 | EP0367767B1 Bacillus thuringiensis p-2 toxin gene, protein and related insecticide compositions |
| 03/12/1997 | CN1145077A Immuno-stimulatory monoclonal antibodies |
| 03/12/1997 | CN1145032A Monoclonal anbibodies which bind to tumor rejection antigen precursor MAGE-1, recombinant MAGE-1, and MAGE-1 derived immunogenic peptides |
| 03/12/1997 | CN1145020A Ancient organisms |
| 03/11/1997 | US5610282 cDNA encoding a rat D1 dopamine receptor linked to adenylyl cyclase activation and expression of the receptor protein in plasmid-transfected cell lines |
| 03/11/1997 | US5610280 Antitumor |
| 03/11/1997 | US5610279 Human TNF receptor |
| 03/11/1997 | US5610276 Determination whether a cell is cancerous |
| 03/11/1997 | US5610067 Method of preparing plasmid having both expressing ability of retroviral gene and processing ability after translation, and resultant plasmid and expression products |
| 03/11/1997 | US5610062 Dispersant solutions for dispersing hydrocarbons |
| 03/11/1997 | US5610048 Xylanase, DNA sequences, coding for the xylanases and methods of use thereof |
| 03/11/1997 | US5610047 Trehalose |
| 03/11/1997 | US5610046 Cloning and expression of xylanase B |
| 03/11/1997 | US5610041 Processes for producing polyhydroxybutyrate and related polyhydroxyalkanoates in the plastids of higher plants |
| 03/11/1997 | US5610039 Oxidizing a glucamine to produce an intermediate compound and reducing intermediate |
| 03/11/1997 | US5610037 Fermentation |
| 03/11/1997 | US5610015 System to detect protein-RNA interactions |
| 03/11/1997 | US5610011 Virulence-encoding DNA sequences of Strepococcus suis and related products and methods |
| 03/11/1997 | US5609724 Fungi for pitch reduction and their preparation |
| 03/11/1997 | EP0699442A4 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties |
| 03/11/1997 | CA1338981C Biologically active proteins and a method for their production |
| 03/06/1997 | WO1997008335A1 Monoclonal antibody recognizing serum amyloid a |
| 03/06/1997 | WO1997008333A1 Process for producing l-amino acids |
| 03/06/1997 | WO1997008324A1 Methods for enhancing the production of interferon in cell culture |
| 03/06/1997 | WO1997008321A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |